Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Fleming

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo ClinicJ A Laurie, C G Moertel, T R Fleming, et al.
Controlled Clinical Trials|December 1, 1995
The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trialsD L DeMets, T R Fleming, R J Whitley, et al.
Hepatology (Baltimore, Md.)|October 1, 1989
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysisR H Wiesner, P M Grambsch, E R Dickson, et al.
Cancer Treatment Reports|November 1, 1985
Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomasJ H Edmonson, G W McCormack, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinomaT R Buroker, C G Moertel, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
The New England Journal of Medicine|February 8, 1990
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinomaC G Moertel, T R Fleming, J S Macdonald, et al.
Sexually Transmitted Diseases|November 24, 1999
Safety and toxicity of nonoxynol-9 gel as a rectal microbicideS R Tabet, C Surawicz, S Horton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancerJ E Krook, J R Jett, T R Fleming, et al.
JAMA|April 12, 1985
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycinS A Cullinan, C G Moertel, T R Fleming, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo ClinicJ A Laurie, C G Moertel, T R Fleming, et al.
Controlled Clinical Trials|December 1, 1995
The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trialsD L DeMets, T R Fleming, R J Whitley, et al.
Hepatology (Baltimore, Md.)|October 1, 1989
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysisR H Wiesner, P M Grambsch, E R Dickson, et al.
Cancer Treatment Reports|November 1, 1985
Comparison of cyclophosphamide plus cisplatin versus hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin in combination as initial chemotherapy for stage III and IV ovarian carcinomasJ H Edmonson, G W McCormack, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinomaT R Buroker, C G Moertel, T R Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
The New England Journal of Medicine|February 8, 1990
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinomaC G Moertel, T R Fleming, J S Macdonald, et al.
Sexually Transmitted Diseases|November 24, 1999
Safety and toxicity of nonoxynol-9 gel as a rectal microbicideS R Tabet, C Surawicz, S Horton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
A controlled evaluation of combined 5-fluorouracil, doxorubicin, and mitomycin C (FAM) for the treatment of advanced non-small-cell lung cancerJ E Krook, J R Jett, T R Fleming, et al.
JAMA|April 12, 1985
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycinS A Cullinan, C G Moertel, T R Fleming, et al.
Pageof 12